197 related articles for article (PubMed ID: 9867062)
1. Pathophysiology of diabetic nephropathy.
Cooper ME; Gilbert RE; Epstein M
Metabolism; 1998 Dec; 47(12 Suppl 1):3-6. PubMed ID: 9867062
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic targets for diabetic nephropathy.
Fukami K; Yamagishi S; Ueda S; Okuda S
Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):83-92. PubMed ID: 17584148
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways in diabetic nephropathy.
Kawanami D; Matoba K; Utsunomiya K
Histol Histopathol; 2016 Oct; 31(10):1059-67. PubMed ID: 27094540
[TBL] [Abstract][Full Text] [Related]
4. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism of diabetic nephropathy].
Ohshiro Y; Takasu N
Nihon Rinsho; 2006 May; 64(5):997-1003. PubMed ID: 16689387
[TBL] [Abstract][Full Text] [Related]
7. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products and the pathogenesis of diabetic nephropathy.
Yamagishi S; Takeuchi M; Makita Z
Contrib Nephrol; 2001; (134):30-5. PubMed ID: 11665285
[No Abstract] [Full Text] [Related]
10. Nephropathy in diabetes.
Satirapoj B
Adv Exp Med Biol; 2012; 771():107-22. PubMed ID: 23393675
[TBL] [Abstract][Full Text] [Related]
11. [Nephrotic syndrome due to metabolic disease--special reference to diabetic nephropathy].
Ohga S; Shikata K; Makino H
Nihon Rinsho; 2004 Oct; 62(10):1907-13. PubMed ID: 15500138
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy.
Rincon-Choles H; Kasinath BS; Gorin Y; Abboud HE
Kidney Int Suppl; 2002 Dec; (82):S8-11. PubMed ID: 12410848
[TBL] [Abstract][Full Text] [Related]
13. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
15. The importance of diabetic nephropathy in current nephrological practice.
Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
[TBL] [Abstract][Full Text] [Related]
16. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy and advanced glycation end products.
Menè P; Festuccia F; Polci R; Pugliese F; Cinotti GA
Contrib Nephrol; 2001; (131):22-32. PubMed ID: 11125560
[No Abstract] [Full Text] [Related]
18. Pathogenetic mechanisms of diabetic nephropathy.
Schena FP; Gesualdo L
J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S30-3. PubMed ID: 15938030
[TBL] [Abstract][Full Text] [Related]
19. AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.
Pathomthongtaweechai N; Chutipongtanate S
Biomed Pharmacother; 2020 Nov; 131():110655. PubMed ID: 32853909
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy.
Forbes JM; Thallas-Bonke V; Cooper ME; Thomas MC
Curr Pharm Des; 2004; 10(27):3361-72. PubMed ID: 15544521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
